Thalidomide prevents the progression of peritoneal fibrosis in mice

Acta Histochemica et Cytochemica

Volumn 44, Issue 2, 2011, Pages 51-60

  Arai, Hideyuki ^a   Furusu, Akira ^a   Nishino, Tomoya ^a,b   Obata, Yoko ^a,c   Nakazawa, Yuka ^a   Nakazawa, Masayuki ^a   Hirose, Misaki ^a   Abe, Katsushige ^d   Koji, Takehiko ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d Jinikai Hospital   (Japan)

Author keywords

PCNA; Peritoneal fibrosis; TGF ; Thalidomide; VEGF

Indexed keywords

MUS;

EID: 79955756312     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.10030     Document Type: Article

References (38)

1. Abo, T., Nagayasu, T., Hishikawa, Y., Tagawa, T., Nanashima, A., Yamayoshi, T., Matsumoto, K., An, S. and Koji, T. (2010) Expression of keratinocyte growth factor and its receptor in rat tracheal cartilage: possible involvement in wound healing of the damaged cartilage. Acta Histochem. Cytochem. 43; 89-98.
2. Aroeira, L. S., Aguilera, A., Sanchez-Tomero, J. A., Bajo, M. A., del Peso, G., Jimenez-Heffernan, J. A., Selgas, R. and Lopez-Cabrera, M. (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J. Am. Soc. Nephrol. 18; 2004-2013.
3. Brimble, K. S., Walker, M., Margetts, P. J., Kundhal, K. K. and Rabbat, C. G. (2006) Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J. Am. Soc. Nephrol. 17; 2591-2598.
4. Brown, E. A., Davies, S. J., Rutherford, P., Meeus, F., Borras, M., Riegel, W., Divino Filho, J. C., Vonesh, E. and van Bree, M. (2003) Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J. Am. Soc. Nephrol. 14; 2948-2957.
5. Calabrese, L. and Fleischer, A. B. (2000) Thalidomide: current and potential clinical applications. Am. J. Med. 108; 487-495.
6. Coles, G. A. and Topley, N. (2000) Long-term peritoneal membrane changes. Adv. Ren. Replace. Ther. 7; 289-301.
7. Combet, S., Miyata, T., Moulin, P., Pouthier, D., Goffin, E. and Devuyst, O. (2000) Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J. Am. Soc. Nephrol. 11; 717-728.
8. D'Amato, R. J., Loughnan, M. S., Flynn, E. and Folkman, J. (1994) Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U S A 91; 4082-4085.
9. Damavandi, E., Hishikawa, Y., Izumi, S., Shin, M. and Koji, T. (2002) Involvement of Bax redistribution in the induction of germ cell apoptosis in neonatal mouse testes. Acta Histochem. Cytochem. 35; 449-459.
10. Devuyst, O., Margetts, P. J. and Topley, N. (2010) The pathophysiology of the peritoneal membrane. J. Am. Soc. Nephrol. 21; 1077-1085.
11. Dvorak, H. F., Brown, L. F., Detmar, M. and Dvorak, A. M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146; 1029-1039.
12. Ferrara, N. (2000) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res. 55; 15-35.
13. Gandhi, V. C., Humayun, H. M., Ing, T. S., Daugirdas, J. T., Jablokow, V. R., Iwatsuki, S., Geis, W. P. and Hano, J. E. (1980) Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch. Intern. Med. 140; 1201-1203.
14. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119; 493-501.
15. Honda, K., Nitta, K., Horita, S., Yumura, W. and Nihei, H. (1996) Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72; 171-176.
16. Io, H., Hamada, C., Ro, Y., Ito, Y., Hirahara, I. and Tomino, Y. (2004) Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 65; 1927-1936.
17. Ishii, Y., Sawada, T., Shimizu, A., Tojimbara, T., Nakajima, I., Fuchinoue, S. and Teraoka, S. (2001) An experimental sclerosing encapsulating peritonitis model in mice. Nephrol. Dial. Transplant. 16; 1262-1266.
18. Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D. and Chapman, H. A. (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. U S A 103; 13180-13185.
19. Lv, P., Luo, H. S., Zhou, X. P., Chireyath Paul, S., Xiao, Y. J., Si, X. M. and Liu, S. Q. (2006) Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress. Pathol. Res. Pract. 202; 777-788.
20. Lv, P., Luo, H. S., Zhou, X. P., Xiao, Y. J., Paul, S. C., Si, X. M. and Zhou, Y. H. (2007) Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factorkappaB/ inhibitor of nuclear factor-kappaB pathway. Arch. Med. Res. 38; 15-27.
21. Lv, P., Paul, S. C., Xiao, Y., Liu, S. and Luo, H. (2006) Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis. Mediators Inflamm. 2006; 93253.
22. Margetts, P. J., Oh, K. H. and Kolb, M. (2005) Transforming growth factor-beta: importance in long-term peritoneal membrane changes. Perit. Dial. Int. 25 Suppl 3; S15-17.
23. Mishima, Y., Miyazaki, M., Abe, K., Ozono, Y., Shioshita, K., Xia, Z., Harada, T., Taguchi, T., Koji, T. and Kohno, S. (2003) Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. Perit. Dial. Int. 23; 14-22.
24. Miyajima, K., Takekoshi, S., Itoh, J., Kakimoto, K., Miyakoshi, T. and Osamura, R. Y. (2010) Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 rats: animal model of VEGF-targeted therapy for human endocrine tumors. Acta Histochem. Cytochem. 43; 33-44.
25. Mondello, S., Mazzon, E., Di Paola, R., Crisafulli, C., Mondello, P., Buemi, M., Aloisi, C. and Cuzzocrea, S. (2009) Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. Shock 32; 332-339.
26. Ni, J., Verbavatz, J. M., Rippe, A., Boisde, I., Moulin, P., Rippe, B., Verkman, A. S. and Devuyst, O. (2006) Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int. 69; 1518-1525.
27. Nishino, T., Miyazaki, M., Abe, K., Furusu, A., Mishima, Y., Harada, T., Ozono, Y., Koji, T. and Kohno, S. (2003) Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int. 64; 887-896.
28. Paravar, T. and Lee, D. J. (2008) Thalidomide: mechanisms of action. Int. Rev. Immunol. 27; 111-135.
29. Paul, S. C., Lv, P., Xiao, Y. J., An, P., Liu, S. Q. and Luo, H. S. (2006) Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factor-kappaB. Pathobiology 73; 82-92.
30. Scotton, C. J. and Chambers, R. C. (2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132; 1311-1321.
31. Shirendeb, U., Hishikawa, Y., Moriyama, S., Win, N., Thu, M. M., Mar, K. S., Khatanbaatar, G., Masuzaki, H. and Koji, T. (2009) Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar. Acta Histochem. Cytochem. 42; 181-190.
32. Tabata, C., Tabata, R., Kadokawa, Y., Hisamori, S., Takahashi, M., Mishima, M., Nakano, T. and Kubo, H. (2007) Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J. Immunol. 179; 708-714.
33. Williams, J. D., Craig, K. J., Topley, N., Von Ruhland, C., Fallon, M., Newman, G. R., Mackenzie, R. K. and Williams, G. T. (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 13; 470-479.
34. Yndestad, A., Vinge, L. E., Bjornerheim, R., Ueland, T., Wang, J. E., Froland, S. S., Attramadal, H., Aukrust, P. and Oie, E. (2006) Thalidomide attenuates the development of fibrosis during postinfarction myocardial remodelling in rats. Eur. J. Heart. Fail. 8; 790-796.
35. Yoshio, Y., Miyazaki, M., Abe, K., Nishino, T., Furusu, A., Mizuta, Y., Harada, T., Ozono, Y., Koji, T. and Kohno, S. (2004) TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int. 66; 1677-1685.
36. Zhang, S., Li, M., Gu, Y., Liu, Z., Xu, S., Cui, Y. and Sun, B. (2008) Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. J. Exp. Clin. Cancer Res. 27; 60.
37. Zweers, M. M., de Waart, D. R., Smit, W., Struijk, D. G. and Krediet, R. T. (1999) Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J. Lab. Clin. Med. 134; 124-132.
38. Zweers, M. M., Struijk, D. G., Smit, W. and Krediet, R. T. (2001) Vascular endothelial growth factor in peritoneal dialysis: a longi- tudinal follow-up. J. Lab. Clin. Med. 137; 125-132.